BlackRock Amends TransMedics Stake, Signals Ownership Change
Ticker: TMDX · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 1756262
| Field | Detail |
|---|---|
| Company | Transmedics Group, Inc. (TMDX) |
| Form Type | SC 13G/A |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock updated its TransMedics stake, watch for details on their new ownership percentage!**
AI Summary
BlackRock, Inc. filed an amended SC 13G/A on January 25, 2024, disclosing its ownership in TransMedics Group, Inc. as of December 31, 2023. This amendment (Amendment No. 3) indicates a change in BlackRock's beneficial ownership of TransMedics' Common Stock. For investors, this matters because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in its confidence in the company's future prospects, potentially influencing other investors' decisions.
Why It Matters
Large institutional investors like BlackRock adjusting their positions can influence market sentiment and stock price, as their moves are often seen as a vote of confidence or concern.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of institutional ownership and does not inherently present a high risk, but changes in ownership can indirectly affect stock volatility.
Analyst Insight
An investor should review the full SC 13G/A filing to determine the exact change in BlackRock's ownership percentage and compare it to previous filings to understand the magnitude of their adjustment in TransMedics Group, Inc. shares.
Key Players & Entities
- BlackRock, Inc. (company) — the reporting person filing the SC 13G/A
- TransMedics Group, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 25, 2024 (date) — the filing date of the SC 13G/A
- Amendment No. 3 (number) — the specific amendment number of the filing
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 3)' sections.
Who is the reporting person in this filing?
The reporting person is BlackRock, Inc., as indicated under '(1)Names of reporting persons. BlackRock, Inc.' and in the 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.' section.
What is the subject company whose securities are being reported?
The subject company is TransMedics Group, Inc., as stated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TransMedics Group, Inc.' and '(Name of Issuer) TransMedics Group, Inc.'.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified under '(Date of Event Which Requires Filing of this Statement) December 31, 2023'.
What is the CUSIP number for the securities reported?
The CUSIP number for the Common Stock of TransMedics Group, Inc. is 89377M109, as listed under '(CUSIP Number) 89377M109'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding TransMedics Group, Inc. (TMDX).